A

argenx

Develops antibody-based therapies for autoimmune diseases

Safety Evidence Medical Lead

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • A medical degree is preferred; candidates with a PhD, PharmD, or comparable scientific qualification may be considered if they demonstrate expertise in immunology and/or patient safety.
  • A strong medical/scientific background with pharmaceutical or biotechnology experience in strategic Medical Affairs, late-stage Clinical Development, Safety Evidence, Patient Safety, or related evidence-generation roles is required.
  • At least 5 years of experience leading scientific or clinical projects/studies is required.
  • Working knowledge of Good Clinical Practice (GCP) and Good Pharmacovigilance Practices (GVP) is required.
  • Candidates must be based in Belgium, Switzerland, or the US Eastern Time zone.
  • Ability to travel as required, up to 20%, is required.
  • Strong strategic, medical, and scientific judgment, connecting evidence to broader product and business questions, is required.
  • Ability to integrate complex safety information across multiple data sources and distinguish meaningful signals and insights from data noise is required.
  • Strong understanding of drug development and evidence generation across the product lifecycle is required.
  • Ability to influence and collaborate effectively in a complex, cross-functional environment is required.
  • Strong scientific communication skills, including translating complex evidence into clear, decision-relevant narratives, are required.
  • High digital and analytical literacy is required, including critically interpreting dashboards, analytical outputs, and AI-generated insights and applying appropriate medical judgment.

Responsibilities

  • Identify opportunities for strategic differentiation by assessing the safety profiles of company products in the context of competitors and the evolving treatment landscape.
  • Identify critical safety evidence gaps and translate them into evidence-generation priorities.
  • Shape and contribute to Integrated Evidence Generation Plans (IEGPs), ensuring safety evidence supports meaningful scientific and strategic questions.
  • Provide medical interpretation and contextualization of safety evidence across multiple data sources, converting complex data into decision-relevant insights.
  • Provide safety expertise to cross-functional teams.
  • Lead late-stage safety-focused studies, including real-world studies.
  • Translate evidence into clear scientific narratives for internal and external stakeholders.
  • Continuously evaluate emerging safety evidence for company products and relevant competitors to identify differentiating attributes, evidence gaps, and emerging opportunities.
  • Integrate safety, clinical, real-world, and scientific evidence to develop a holistic understanding of product safety profiles.
  • Translate complex evidence into actionable insights that inform evidence strategy and cross-functional decision-making.
  • Partner with Real-World Evidence (RWE), Medical Affairs, Global Patient Safety (GPS), Regulatory, Health Economics and Outcomes Research (HEOR), Clinical Development, Clinical Science, and Biostatistics to shape evidence-generation priorities and Integrated Evidence Generation Plans.
  • Lead the strategy, design, interpretation, and scientific communication of safety-focused studies, including post-authorization safety studies (PASS).
  • Provide medical and safety leadership for interpretation of safety endpoints and outcomes in real-world studies.
  • Ensure evidence generation addresses questions relevant to patients, healthcare professionals, and other relevant stakeholders.
  • Serve as a medical and scientific thought partner on safety evidence across functions.
  • Develop scientific narratives that contextualize safety findings and articulate their relevance for company therapies.
  • Partner with Scientific Communications to integrate safety evidence into publication strategies.
  • Engage external experts and key opinion leaders (KOLs) to strengthen evidence strategies and scientific understanding.

Desired Qualifications

  • Intellectual curiosity and a proactive, solution-oriented mindset.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs